Safety and tolerability of atopaxar (E5555) in acute coronary syndromes: The LANCELOT-ACS trial

Michelle O'Donoghue, David J. Moliterno

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)635-636
Number of pages2
JournalP and T
Volume35
Issue number11
StatePublished - Nov 2010

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Safety and tolerability of atopaxar (E5555) in acute coronary syndromes: The LANCELOT-ACS trial'. Together they form a unique fingerprint.

Cite this